A detailed history of Pinnacle Associates LTD transactions in Sanofi stock. As of the latest transaction made, Pinnacle Associates LTD holds 11,221 shares of SNY stock, worth $548,258. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,221
Previous 12,077 7.09%
Holding current value
$548,258
Previous $600,000 9.17%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$45.75 - $52.48 $39,162 - $44,922
-856 Reduced 7.09%
11,221 $545,000
Q4 2023

Jan 19, 2024

SELL
$43.13 - $54.79 $17,510 - $22,244
-406 Reduced 3.25%
12,077 $600,000
Q3 2023

Oct 23, 2023

SELL
$50.95 - $55.2 $458 - $496
-9 Reduced 0.07%
12,483 $669,000
Q2 2023

Jul 26, 2023

SELL
$50.45 - $57.18 $86,774 - $98,349
-1,720 Reduced 12.1%
12,492 $673,000
Q1 2023

May 04, 2023

SELL
$45.86 - $54.45 $48,107 - $57,118
-1,049 Reduced 6.87%
14,212 $773,000
Q4 2022

Jan 31, 2023

SELL
$38.86 - $48.55 $1,787 - $2,233
-46 Reduced 0.3%
15,261 $739,000
Q4 2022

Jan 25, 2023

BUY
$38.86 - $48.55 $2,215 - $2,767
57 Added 0.37%
15,307 $0
Q3 2022

Oct 31, 2022

BUY
$37.22 - $100.5 $36,401 - $98,289
978 Added 6.85%
15,250 $580,000
Q2 2022

Aug 02, 2022

SELL
$48.99 - $57.46 $2,939 - $3,447
-60 Reduced 0.42%
14,272 $714,000
Q1 2022

May 05, 2022

SELL
$48.48 - $53.65 $14,592 - $16,148
-301 Reduced 2.06%
14,332 $736,000
Q4 2021

Feb 02, 2022

BUY
$47.07 - $52.35 $7,907 - $8,794
168 Added 1.16%
14,633 $733,000
Q3 2021

Oct 19, 2021

SELL
$47.89 - $53.12 $29,835 - $33,093
-623 Reduced 4.13%
14,465 $697,000
Q2 2021

Aug 02, 2021

BUY
$49.36 - $54.25 $888 - $976
18 Added 0.12%
15,088 $795,000
Q1 2021

May 12, 2021

SELL
$45.46 - $50.51 $60,598 - $67,329
-1,333 Reduced 8.13%
15,070 $745,000
Q4 2020

Jan 26, 2021

SELL
$45.3 - $51.62 $59,297 - $67,570
-1,309 Reduced 7.39%
16,403 $797,000
Q3 2020

Oct 23, 2020

BUY
$49.47 - $53.77 $87,166 - $94,742
1,762 Added 11.05%
17,712 $889,000
Q2 2020

Aug 14, 2020

BUY
$42.91 - $52.5 $3,904 - $4,777
91 Added 0.57%
15,950 $814,000
Q1 2020

May 13, 2020

SELL
$38.02 - $51.66 $160,482 - $218,056
-4,221 Reduced 21.02%
15,859 $693,000
Q4 2019

Feb 03, 2020

SELL
$44.25 - $50.86 $261,075 - $300,074
-5,900 Reduced 22.71%
20,080 $1.01 Million
Q3 2019

Nov 08, 2019

SELL
$40.34 - $46.64 $87,497 - $101,162
-2,169 Reduced 7.71%
25,980 $1.2 Million
Q2 2019

Aug 05, 2019

SELL
$40.43 - $44.3 $39,621 - $43,414
-980 Reduced 3.36%
28,149 $1.22 Million
Q1 2019

May 10, 2019

SELL
$40.83 - $45.43 $80,884 - $89,996
-1,981 Reduced 6.37%
29,129 $1.29 Million
Q4 2018

Feb 05, 2019

SELL
$41.48 - $45.59 $47,453 - $52,154
-1,144 Reduced 3.55%
31,110 $1.35 Million
Q3 2018

Nov 13, 2018

SELL
$40.0 - $44.84 $16,000 - $17,936
-400 Reduced 1.22%
32,254 $1.44 Million
Q2 2018

Aug 08, 2018

BUY
$37.63 - $41.22 $20,508 - $22,464
545 Added 1.7%
32,654 $1.31 Million
Q1 2018

May 11, 2018

SELL
$38.98 - $45.76 $143,056 - $167,939
-3,670 Reduced 10.26%
32,109 $1.29 Million
Q4 2017

Feb 12, 2018

BUY
$42.86 - $50.61 $14,958 - $17,662
349 Added 0.99%
35,779 $1.54 Million
Q3 2017

Nov 13, 2017

BUY
$47.04 - $50.34 $23,520 - $25,170
500 Added 1.43%
35,430 $1.76 Million
Q2 2017

Aug 09, 2017

BUY
N/A
34,930
34,930 $1.67 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $123B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.